Skip to content

Biphasic Defibrillation Study: Trial to Compare Fixed Versus Escalating Energy

A Pilot Randomized Controlled Trial to Compare Fixed Versus Escalating Energy Regimens for Biphasic Waveform Defibrillation

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00212992
Enrollment
221
Registered
2005-09-21
Start date
2001-03-31
Completion date
2006-07-31
Last updated
2025-04-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Arrest

Keywords

defibrillation, ventricular fibrillation, heart arrest

Brief summary

This study will compare the effect of constant low-level energy \[150 joules\] to an escalating energy \[200-300-360 joules\] regimen of biphasic waveform defibrillation on multiple patient outcomes.

Detailed description

This pilot, which will enroll 200 subjects, will allow a reasonable estimate of effect size and this will, in turn, allow for the accurate design and planning of a definitive randomized controlled trial. The following outcomes will be evaluated: 1. Important Clinical Outcomes: * Successful conversion, * Resuscitation to one hour, * Survival to hospital discharge, * Neurological function, and * Quality of life. 2. Process Outcomes: * Number of shocks required, * Recurrences of VF, and * Responsiveness to varying periods of pulselessness. 3. Adverse Outcomes: * Myocardial damage.

Interventions

PROCEDUREFixed lower-energy defibrillation

Every shock administered at 150 J

PROCEDUREEscalating higher-energy defibrillation

First shock administered at 200 J, second shock at 300 J, all subsequent shocks at 360 J

Sponsors

Ottawa Hospital Research Institute
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
8 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Witnessed cardiac arrest out-of-hospital requiring defibrillation and given by first responder using an automated external defibrillator

Exclusion criteria

* Terminal illness or do-not-resuscitate (DNR) status * No cardiopulmonary resuscitation (CPR) x 10 minutes * Acute trauma * Exsanguination * Cardiac arrest experienced while in hospital

Design outcomes

Primary

MeasureTime frame
Successful Conversion to an Organized Heart RhythmTermination of defibrillation

Secondary

MeasureTime frameDescription
Survival to Hospital Discharge30 days
Resuscitation for Survival to One HourOne hour from termination of defibrillation
Neurologic Function30 daysThe Cerebral Performance Category Score (CPC) is a five-point scale used to assess neurological outcomes after cardiac arrest. The best score, 1, indicates good cerebral performance. The worst score, 5, represents brain death.
Return of Spontaneous CirculationTermination of defibrillation
Survival to 24 Hours24 hours

Countries

Canada

Participant flow

Participants by arm

ArmCount
Fixed Lower-energy
Out-of-hospital cardiac arrest patients undergoing defibrillation received a fixed lower-energy regimen of 150 J for all shocks
114
Escalating Higher-energy
Out-of-hospital cardiac arrest patients undergoing defibrillation received an escalating higher-energy regimen beginning with 200 J, proceeding to 300 J for the second shock and 360 J for all remaining shocks
107
Total221

Baseline characteristics

CharacteristicEscalating Higher-energyTotalFixed Lower-energy
Age, Continuous66.1 Years
STANDARD_DEVIATION 14.5
66.0 Years
STANDARD_DEVIATION 14.4
66.0 Years
STANDARD_DEVIATION 14.2
Initial Rhythm
Asystole
0 Participants6 Participants6 Participants
Initial Rhythm
Pulseless electrical activity
4 Participants9 Participants5 Participants
Initial Rhythm
VT/VF
103 Participants206 Participants103 Participants
Race and Ethnicity Not Collected0 Participants
Region of Enrollment
Canada
107 participants221 participants114 participants
Sex: Female, Male
Female
18 Participants44 Participants26 Participants
Sex: Female, Male
Male
89 Participants177 Participants88 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 1140 / 107
serious
Total, serious adverse events
0 / 1140 / 107

Outcome results

Primary

Successful Conversion to an Organized Heart Rhythm

Time frame: Termination of defibrillation

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Fixed Lower-energySuccessful Conversion to an Organized Heart Rhythm28 Participants
Escalating Higher-energySuccessful Conversion to an Organized Heart Rhythm39 Participants
Secondary

Neurologic Function

The Cerebral Performance Category Score (CPC) is a five-point scale used to assess neurological outcomes after cardiac arrest. The best score, 1, indicates good cerebral performance. The worst score, 5, represents brain death.

Time frame: 30 days

Population: Patients who survived to hospital discharge

ArmMeasureValue (MEDIAN)
Fixed Lower-energyNeurologic Function2 score on a scale
Escalating Higher-energyNeurologic Function2 score on a scale
Secondary

Resuscitation for Survival to One Hour

Time frame: One hour from termination of defibrillation

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Fixed Lower-energyResuscitation for Survival to One Hour54 Participants
Escalating Higher-energyResuscitation for Survival to One Hour44 Participants
Secondary

Return of Spontaneous Circulation

Time frame: Termination of defibrillation

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Fixed Lower-energyReturn of Spontaneous Circulation58 Participants
Escalating Higher-energyReturn of Spontaneous Circulation52 Participants
Secondary

Survival to 24 Hours

Time frame: 24 hours

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Fixed Lower-energySurvival to 24 Hours37 Participants
Escalating Higher-energySurvival to 24 Hours38 Participants
Secondary

Survival to Hospital Discharge

Time frame: 30 days

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Fixed Lower-energySurvival to Hospital Discharge19 Participants
Escalating Higher-energySurvival to Hospital Discharge17 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026